Organ Transplantation Market Report Market : Facts, Figures and Analytical Insights 2020-2023

The Organ Transplantation Market Report Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The global organ transplantation market is estimated to reach US$18.21 billion in 2023, growing at a CAGR of 11.77% for the period spanning 2019-2023.

The growth of the market has been driven by the growing elderly population, expanding urbanization, rising healthcare spending, accelerating economic growth and increasing obesity rates. Some of the noteworthy trends of the market include rising prevalence of chronic diseases, upsurge in alcohol consumption, advancements in technological innovations and growth in transplant tourism. However, growth of the market would be challenged by high cost of treatment, organ rejection and shortage of organ donors.

Buy The Report (USD $1800 only):
https://www.marketinsightsreports.com/report/purchase/04282009330?mode=su?source=openpr&Mode=12

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Organ Transplantation Market Report Market: XVIVO Perfusion AB, Novartis International AG, Veloxis Pharmaceuticals, Inc., Astellas Pharma, Inc., Pfizer, Inc. and Roche and others.

Industry News:

Apr 06, 2020: Lupin launches generic drug used for prevention of organ rejection in kidney transplant in US

Drug firm Lupin NSE 8.88 % on Monday said it has launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection in patients receiving kidney transplants in the US market. The company has launched the tablets in the strengths of 180 mg and 360 mg, Lupin said in a statement. Company's alliance partner Concord Biotech Ltd had received an approval from the United States Food and Drug Administration (USFDA) earlier for the product, it added.

The tablets are generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets, 180 mg and 360 mg, Lupin said. According to IQVIA MAT February 2020 data, Mycophenolic acid delayed-release tablets USP had an annual sales of around USD 156 million in the US, it added.

ZWIJNAARDE (Ghent), Belgium, July 17, 2019: Today, MyCartis and XVIVO Perfusion AB announce a collaboration to engage in the development of a fast diagnostic tool to timely assess the quality of donated organs during ex-vivo perfusion. Such test can guide the transplant surgeon and team on the quality of an organ and the chances of a positive outcome for the recipient.

Despite yearly growing transplantation numbers, organ waiting lists continue to grow. The organ shortage represents a huge burden for the patient, for his or her direct environment, for the healthcare system and for the overall community.
Ex vivo evaluation of solid donor organs by normothermic machine perfusion is becoming increasingly established as a tool to increase the number of available organs. XVIVO Perfusion is a leading medical technology company focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation.

Basel, June 6, 2019 - Novartis announced today new early stage histology data in kidney transplantation, suggesting that with investigational compound iscalimab (CFZ533) it may be possible to prolong the durability of transplanted kidneys as well as to potentially improve long-term outcomes for kidney transplant patients.

"Extending the life of transplanted kidneys would mean fewer patients going back on dialysis or needing a second transplant - relieving pressure on waiting lists that in the US are already three-to-five years long," said Eric Hughes, Global Development Unit Head, Immunology, Hepatology and Dermatology. "In our journey to reimagine care for patients, I'm excited about the potential of durable transplants becoming a reality."

Market Overview:

The global organ transplantation market is categorized on the basis of organ type, product type and end user. On the basis of organ type, the global organ transplantation market can broadly be divided as heart, kidney, lung, liver, pancreas and others. In terms of product type, the global market can be categorized into organ preservation solutions, immunosuppressive drugs and others. On the basis of end user, the global organ transplantation market can segmented into hospitals, transplant centers and others.

The fastest growing regional market is Europe and Middle East due to expanding urbanization, developed medical sector, encouragement for organ donation, and increasing expenditures on healthcare. North America represents one of the largest organ transplantation market and is already well-penetrated at developed market levels. Asia Pacific region is an emerging market where growth lies in development in the healthcare industry, presence of a huge patient population pool and the availability of skilled professionals and large population suffering from chronic diseases.

Click the link to get a Sample Copy of the Report:
https://www.marketinsightsreports.com/reports/04282009330/global-organ-transplantation-market-by-organ-type-product-type-end-users-insights-trends-forecast-2019-2023/inquiry?source=openpr&Mode=12

Regional Analysis For Organ Transplantation Market Report Market:

For comprehensive understanding of market dynamics, the global Organ Transplantation Market Report market is analyzed across key geographies namely:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Organ Transplantation Market Report Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2020–2026.

Following are major Table of Content of Organ Transplantation Market Report Market:

- Global Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
- Global Market competition by top Players
- Analysis by Regions
- Consumption by Regions
- Consumption, By Types, Revenue and Market share by Types
- Consumption, By Applications, Market share (%) and Growth Rate by Applications
- Complete profiling and analysis of Players
- Industrial Chain, Sourcing Strategy and Downstream Buyers
- Marketing Strategy Analysis, Distributors/Traders
- Global Market Effect Factors Analysis
- Global Market Forecast
- Global Market Research Findings and Conclusion, Appendix, methodology and data source

Finally, all aspects of the Global Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects. The report supplies the international economic competition with the assistance of Porter’s Five Forces Analysis and SWOT Analysis.

For More Information On This Report, Please Visit: https://www.marketinsightsreports.com/reports/04282009330/global-organ-transplantation-market-by-organ-type-product-type-end-users-insights-trends-forecast-2019-2023?source=openpr&Mode=12

We Offer Customization On Report Based On Specific Client Requirement:

– Free country Level analysis for any 5 countries of your choice.
– Free Competitive analysis of any 5 key market players.
– Free 40 analyst hours to cover any other data point.

How we have factored the effect of Covid-19 in our report:

All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

CONTACT US:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.